TNFRSF8 and neoplasm: Importantly, antibody–drug conjugates (ADCs) targeting CD30 can exert cytotoxic effects on Neighboring CD30-negative tumor cells through a bystander effect, whereby the cytotoxic payload diffuses to adjacent CD30-negative tumor cells [33].